Esther Lukasiewicz Hagai
VP Clinical & Medical Affairs
Stem Cells
Pluristem Therapeutics, Inc
Israel
Biography
Dr. Lukasiewicz-Hagai has twelve years' experience in Drug development. She joins Pluristem from Teva Global R&D, where she was Director, Clinical Program Leader, leading the global clinical development of multiple biosimilars and innovative drugs in various Oncologic and Neuropsychiatric indications.
Research Interest
She previously worked at Gertner Institute for Epidemiology and Health Policy Research (Sheba Medical Center, Tel Hashomer) where she was responsible of multiple national and US-Israeli clinical trials in Orthopedic and Hemato-Oncologic indications. Dr Lukasiewicz-Hagai holds a M.D. and a Medical Residency in Public Health and Social Medicine from Necker-Enfants Malades Paris V School of Medicine In addition, she holds a Master of Methodology and Statistics in Clinical Research and a M. Med. Sc. in Biostatistics and Epidemiology from Paris XI as well as a Ph.D. in Biostatistics from Bar-Ilan University.